The Oklahoma Shared Clinical and Translational Resources

The OSCTR is funded by the National Institutes of Health as part of its IDeA-CTR program. We have the mission to serve as a catalyst for clinical and translational research that improves health and healthcare for Oklahomans, to provide training and infrastructure to help junior investigators to launch independent research careers, and to expand the opportunities of IDeA states and Oklahoma communities to participate in research that improves the health of our residents. 

Oklahoma Clinical and Translational Science Institute

 

OCTSI is the home of the OSCTR, as well as clinical research services and dissemination and implementation resources to help improve the delivery of healthcare. 

Oklahoma Primary Healthcare Improvement Cooperative

 

OPHIC is the implementation science arm of a statewide network to help improve healthcare delivery assisting primary care practices to adopt evidence-based best practices for the care of their patients.

OCTSI Clinical Research Unit

​​

The OCTSI CRU assists medical providers to identify and conduct clinical research opportunities in Oklahoma.

OU Health Campus Celebrates Dr. Stavrakis’ Election to ASCI and His Leadership in Translational Cardiac Research

On Tuesday, March 2nd, 2026, the American Society of Clinical Investigation (ASCI) elected Stavros Stavrakis, MD, PhD, to their historic ranks. Dr. Stavrakis was one of the earliest graduates of the Master of Science in Clinical Translational Science program offered by the University of Oklahoma Health Campus’s Clinical and Translational Science Institute (OCTSI). ASCI last elected a clinician from Oklahoma in 2003, marking this inclusion as a truly significant moment in the history of Oklahoman healthcare.

University of Oklahoma Health Sciences Receives Federal Funding to Improve Health Care Access Across the State

Across large areas of Oklahoma and the nation, primary care clinics are a lifeline, providing care for people who otherwise would have to travel many miles to see a doctor. To increase access to vital health care, the National Institutes of Health announced an ambitious new initiative to integrate NIH-funded clinical trials into routine patient care in areas like rural Oklahoma and within Tribal nations.

Subscribe to News

Recent Publications

HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative

Open Forum Infect Dis. 2026 Jan 15;13(1):ofaf731. doi: 10.1093/ofid/ofaf731. eCollection 2026 Jan.

ABSTRACT

BACKGROUND: While disparities in COVID-19 therapeutic access have been documented, the effect of HIV status on treatment access and how it intersects with other sociodemographic factors has not been well explored. Using data from the National Clinical Cohort Collaborative (N3C), we investigated disparities in COVID-19 therapeutic prescription among persons with HIV and without HIV.

Upcoming Events

Media